ECOG- Frequently Asked Questions about the ECOG Clinical Trial for Patients with Metastatic or Recurrent Colorectal Cancer (E4203)
Follow the link below to view the handout answering frequently asked questions about the E4203, ECOG Clinical Trial for Patients with Metastatic or Recurrent Colorectal Cancer. This is a "Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer".
The document is in Adobe Acrobat format. If you do not already
have Adobe Acrobat Reader running on your computer you can
download this software free of charge from the Adobe web site.
How to contact ECOG
All contents copyright © 2001 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: August 18, 2006